New base $2 Well we have to see what interim news on trial is on Monday . Market is expecting at least two or hopefully three insulin independent patients . Hopefully share price bases here, again the fact competition is failing and the clinical results are holding are factors in the share price .
The real catalyst will be any pharma deal of substance .
@Ripix ..... now why would anybody sell just before a major catalyst ? Didn't you sell a whole,e bunch before at 4o cents before news came out before it took off to $1.30?
Werent you crying managemen5 wasn't buying any stock for Bitk?
MS